Indirubin-3'-(2,3 dihydroxypropyl)-oximether (E804) is a potent modulator of LPS-stimulated macrophage functions

Toxicology and Applied Pharmacology

Volumn 266, Issue 1, 2013, Pages 157-166

  Babcock, Abigail S ^a   Anderson, Amy L ^a   Rice, Charles D ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

COX 2; IL 10; IL 6; Indirubin 3' (2,3 dihydroxypropyl) oximether (E804); INOS; LPS; Phagocytosis and intracellular killing; RAW264.7 macrophages

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; INDIRUBIN; INDIRUBIN 3' (2,3 DIHYDROXYPROPYL)OXIMETHER; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYSOZYME; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FOLLOW UP; GENE EXPRESSION; GENETIC ASSOCIATION; IMMUNOMODULATION; INTRACELLULAR KILLING; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHAGOCYTOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STRESS; UPREGULATION;

ANIMALS; CELL LINE; IMMUNOLOGIC FACTORS; INDOLES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PHAGOCYTOSIS;

DANGGUI; MURINAE;

EID: 84870332617     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.10.011     Document Type: Article

References (53)

1. Adachi J., Mori Y., Matsui S., Takigami H., Fujino J., Kitagawa J., Miller C.A., Kato T., Saeki K., Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 2001, 276:31475-31478.
2. Adachi J., Mori Y., Matsui S., Matsuda T. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol. Sci. 2004, 80:161-169.
3. Boleza K.A., Burnett L.E., Burnett K.G. Hypercapnic hypoxia compromises bactericidal activity of fish anterior kidney cells against opportunistic environmental pathogens. Fish Shellfish Immunol. 2001, 11:593-610.
4. Bozzaro S., Merkl R., Gerisch G. Chapter 20 cell adhesion: its quantification, assay of the molecules involved, and selection of defective mutants in dictyostelium and polysphondylium. Methods in Cell Biology 1987, 359-385. Academic Press. A.S. James (Ed.).
5. Burton J.E., Dorociak I.R., Schwedler T.E., Rice C.D. Circulating lysozyme and hepatic CYP1A activities during a chronic dietary exposure to tributyltin (TBT) and 3,3',4,4',5-pentachlorobiphenyl (PCB-126) mixtures in channel catfish, Ictalurus punctatus. J. Toxicol. Environ. Health A 2002, 65:589-602.
6. Cabello J., Neukomm L.J., Günesdogan U., Burkart K., Charette S.J., Lochnit G., Hengartner M.O., Schnabel R. The Wnt pathway controls cell death engulfment, spindle orientation, and migration through CED-10/Rac. PLoS Biol. 2010, 8:e1000297.
7. Cancello R., Clement K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006, 113:1141-1147.
8. Chan L.L.Y., Cheung B.K.W., Li J.C.B., Lau A.S.Y. A role for STAT3 and cathepsin S in IL-10 down-regulation of IFN-γ-induced MHC class II molecule on primary human blood macrophages. J. Leukoc. Biol. 2010, 88:303-311.
9. Chan Y.-K., Kwok H.-H., Chan L.-S., Leung K.S.-Y., Shi J., Mak N.-K., Wong R.N.-S., Yue P.Y.-K. An indirubin derivative, E804, exhibits potent angiosuppressive activity. Biochem. Pharmacol. 2012, 83:598-607.
10. Chanteux H., Guisset A.C., Pilette C., Sibille Y. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. BioMed. Cent. Respir. Res. 2007, 8:71-81.
11. Crinelli R., Antonelli A., Bianchi M., Gentilini L., Scaramucci S., Magnani M. Selective inhibition of NF-kB activation and TNF-α production in macrophages by red blood cell-mediated delivery of dexamethasone. Blood Cells Mol. Dis. 2000, 26:211-222.
12. Dall'Asta M., Derlindati E., Ardigò D., Zavaroni I., Brighenti F., Del Rio D. Macrophage polarization: the answer to the diet/inflammation conundrum?. Nutr. Metab. Cardiovasc. Dis. 2012, 22:387-392.
13. Denison M.S., Pandini A., Nagy S.R., Baldwin E.P., Bonati L. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 2002, 141:3-24.
14. Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González Á., Esquivel-Chirino C., Durante-Montiel I., Sánchez-Rivera G., Valadez-Vega C., Morales-González J.A. Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci. 2011, 12:3117-3132.
15. Gannon C.J., Malone D.L., Napolitano L.M. Reduction of IL-10 and nitric oxide synthesis by SR31747A (sigma ligand) in RAW murine macrophages. Surg. Infect. 2001, 2:267-273.
16. Gordon M.A., Jack D.L., Dockrell D.H., Lee M.E., Read R.C. Gamma interferon enhances internalization and early nonoxidative killing of Salmonella enterica serovar Typhimurium by human macrophages and modifies cytokine responses. Infect. Immun. 2005, 73:3445-3452.
17. Gu Y.-Z., Hogenesch J.B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 2000, 40:519-561.
18. Hickey M.J., Sihota E., Amrani A., Santamaria P., Zbytnuik L.D., Ng E.S.M., Ho W., Sharkey K.A., Kubes P. Inducible nitric oxide synthase (iNOS) in endotoxemia: chimeric mice reveal different cellular sources in various tissues. The FASEB Journal 2002, 16:1141-1143.
19. Hoessel R., Leclerc S., Endicott J.A., Nobel M.E.M., Lawrie A., Tunnah P., Leost M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., Meijer L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1999, 1:60-67.
20. Hu W., Sorrentino C., Denison M.S., Kolaja K., Fielden M.R. Induction of Cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol. Pharmacol. 2007, 71:1475-1486.
21. Jensen B.A., Leeman R.J., Schlezinger J.J., Sherr D.H. Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study. Environ. Health 2003, 2:16-28.
22. Jung H.J., Nam K.N., Son M.S., Kang H., Hong J.W., Kim J.W., Lee E.H. Indirubin-3'-oxime inhibits inflammatory activation of rat brain microglia. Neurosci. Lett. 2011, 487:139-143.
23. Kaminski N.E., Kaplan B.A., Holsapple M.P. Toxic responses of the immune system. Casarett & Doull's Toxicology: The Basic Science of Poisons 2008, 485-555. McGraw-Hill Health Professions Division, New York, NY. 7th edition. C. Klaassen, M.O. Amdur, J. Doull (Eds.).
24. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T.M., Atkinson M.A., Agarwal A. Heme Oxygenase-1 Modulates Early Inflammatory Responses: Evidence from the Heme Oxygenase-1-Deficient Mouse. The American journal of pathology 2004, 165:1045-1053.
25. Kawanishi M., Sakamoto M., Ito A., Kishi K., Yagi T. Construction of reporter yeasts for mouse aryl hydrocarbon receptor ligand activity. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2003, 540:99-105.
26. Knockaert M., Blondel M., Bach S., Leost M., Elbi C., Hager G.L., Nagy S.R., Han D., Denison M., Ffrench M., Ryan X.P., Magiatis P., Polychronopoulos P., Greengard P., Skaltsounis L., Meijer L. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004, 23:4400-4412.
27. Kohle C., Bock K.W. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem. Pharmacol. 2007, 73:1853-1862.
28. Krueger J.G., Krane J.F., Carter D.M., Gottlieb A.B. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J. Invest. Dermatol. 1990, 94:135S-140S.
29. Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J.A., Snyder G.L., Greengard P., Biernat J., Wu Y.Z., Mandelkow E.M., Eisenbrand G., Meijer L. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J. Biol. Chem. 2001, 276:251-260.
30. Mantovani A. Macrophage diversity and polarization: in vivo veritas. Blood 2006, 108:408-409.
31. Marko D., Schatzle S., Friedel A., Genzlinger A., Zankl H., Meijer L., Eisenbrand G. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br. J. Cancer 2001, 84:283-289.
32. Marques C.P., Cheeran M.C.-J., Palmquist J.M., Hu S., Lokensgard J.R. Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J. Neurovirol. 2008, 14:229-238.
33. Matsukawa A., Kudo S., Maeda T., Numata K., Watanabe H., Takeda K., Akira S., Ito T. Stat3 in resident macrophages as a repressor protein of inflammatory response. J. Immunol. 2005, 175:3354-3359.
34. Meijer L., Skaltsounis A.-L., Magiatis P., Polychronopoulos P., Knockaert M., Leost M., Ryan X.P., Vonica C.A., Brivanlou A., Dajani R., Crovace C., Tarricone C., Musacchio A., Roe S.M., Pearl L., Greengard P. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem. Biol. 2003, 10:1255-1266.
35. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
36. Naito Y., Takagi T., Yoshikawa T. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment. Pharmacol. Ther. 2004, 20:177-184.
37. Nam S., Buettner R., Turkson J., Kim D., Cheng J.Q., Muehlbeyer S., Hippe F., Vatter S., Merz K.H., Eisenbrand G., Jove R. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5998-6003.
38. Nam S., Scuto A., Yang F., Chen W., Park S., Yoo H.S., Konig H., Bhatia R., Cheng X., Merz K.H., Eisenbrand G., Jove R. Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling. Mol. Oncol. 2012.
39. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 2000, 59:65-85.
40. Parry R.M., Chandau R.C., Shahani R.M. A rapid and sensitive assay of muramidase. Proc. Soc. Exp. Biol. Med. 1965, 119:384-386.
41. Peppelenbosch M.P., DeSmedt M., ten Hove T., van Deventer S.J.H., Grooten J. Lipopolysaccharide regulates macrophage fluid phase pinocytosis via CD14-dependent and CD14-independent pathways. Blood 1999, 93:4011-4018.
42. Peracino B., Borleis J., Jin T., Westphal M., Schwartz J.-M., Wu L., Bracco E., Gerisch G., Devreotes P., Bozzaro S. G protein ? subunit-null mutants are impaired in phagocytosis and chemotaxis due to inappropriate regulation of the actin cytoskeleton. J. Cell Biol. 1998, 141:1529-1537.
43. Polychronopoulos P., Magiatis P., Skaltsounis A.-L., Myrianthopoulos V., Mikros E., Tarricone A., Musacchio A., Roe S.M., Pearl L., Leost M., Greengard P., Meijer L. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. J. Med. Chem. 2004, 47:935-946.
44. Sheikh S.Z., Hegazi R.A., Kobayashi T., Onyiah J.C., Russo S.M., Matsuoka K., Sepulveda A.R., Li F., Otterbein L.E., Plevy S.E. An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J. Immunol. 2011, 186:5506-5513.
45. Shim E.-K., Kim J.-K. Indirubin derivative E804 inhibits angiogenesis. BMC Cancer 2012, 12:164.
46. Spink B.C., Hussain M.M., Katz B.H., Eisele L., Spink D.C. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem. Pharmacol. 2003, 66:2313-2321.
47. Springs A.E., Rice C.D. The effects of indirubin-3'-monoxime, a novel AHR ligand, on stress and toxicity-related gene/protein expression in human U937 cells undergoing differentiation and activation. J. Immunotoxicol. 2006, 3:1-10.
48. Sugawara T., Gallucci R.M., Simeonova P.P., Luster M.I. Regulation and role of interleukin-6 in wounded human epithelial keratinocytes. Cytokine 2001, 15:328-336.
49. Tim M. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
50. Tsai J.-T., Liu H.-C., Chen Y.-H. Suppression of inflammatory mediators by cruciferous vegetable-derived indole-3-carbinol and phenylethyl isothiocyanate in lipopolysaccharide-activated macrophages. Mediat. Inflamm. 2010.
51. Vincenti M.P., Burrell T.A., Taffet S.M. Regulation of NF-κB activity in murine macrophages: effect of bacterial lipopolysaccharide and phorbol ester. J. Cell. Physiol. 1992, 150:204-213.
52. Wu L., Yang Y., Zu Z. Studies on the active principles of indigofera in the treatment of CML. Comm. Chin. Herb. Med. 1979, 9:6-8.
53. Yehuda R., Yang R.-K., Ling Guo S., Makotkine I., Singh B. Relationship between dexamethasone-inhibited lysozyme activity in peripheral mononuclear leukocytes and the cortisol and glucocorticoid receptor response to dexamethasone. J. Psychiatr. Res. 2003, 37:471-477.